David V Elkins insider trades

Open-market stock purchases and sales by David V Elkins, EVP, Chief Financial Officer at Bristol Myers Squibb Co, from SEC Form 4 filings since Nov 23, 2010.

Recent trades

DateStockTradeValue
Apr 1, 2026BMY Bristol Myers Squibb CoSold$1.6M
Apr 1, 2026BMY Bristol Myers Squibb CoSold$278K
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)$173K
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)$180K
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoBought (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)—
Mar 10, 2026BMY Bristol Myers Squibb CoSold (not open market)$616K
Nov 13, 2025TPR Tapestry, IncBought (not open market)$200K

Companies traded

  • BMY Bristol Myers Squibb Co: 7 sales, last Apr 1, 2026
  • TPR Tapestry, Inc: other filings, last Nov 13, 2025
  • CELG Celgene Corp /de/: other filings, last Nov 20, 2019
  • BDX Becton Dickinson & Co: 1 sale, last Nov 9, 2012

Get free alerts when David V Elkins files a new trade →